Integra LifeSciences gains on annual profit forecast raise

Integra LifeSciences Holdings

26/10/2022 17:43

** Shares of medical equipment maker Integra LifeSciences
Holdings Corp  IART.O  up ~6% at $47.10 
    ** Stock set for its best day in nearly a year if gains hold
    ** Co raises its full-year adjusted EPS forecast to a range
of $3.29 to $3.33 from its previous outlook of between $3.12 and
$3.20  urn:newsml:reuters.com:*:nGNX74fmS0
    ** Co also says it is targeting to return its intracranial
pressure monitors, recalled after reports of out-of-range
pressure readings, to market in H1 of 2023
    ** IART reports Q3 adjusted profit of $0.86/shr, above
Refinitiv IBES estimates of $0.72
    ** Including session moves, stock down ~30% YTD
 (Reporting by Raghav Mahobe)
 ((Raghav.Mahobe@thomsonreuters.com;))